User profiles for M. Matsunawa

Manabu Matsunawa

Verified email at pure.ocn.ne.jp
Cited by 240

[HTML][HTML] Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia

M Ishizawa, M Matsunawa, R Adachi, S Uno… - Journal of lipid …, 2008 - ASBMB
… The proteins were dissolved in 0.05 M phosphate buffer (pH 7.5) containing 0.3 M KCl and
5 mM DTT and were incubated with [26,27-methyl- 3 H]1,25(OH) 2 D 3 at 4C in the presence …

The Aryl Hydrocarbon Receptor Activator Benzo[a]pyrene Enhances Vitamin D3 Catabolism in Macrophages

M Matsunawa, Y Amano, K Endo, S Uno… - Toxicological …, 2009 - academic.oup.com
M. Matsunawa was a Postdoctoral Fellow supported by a grant from the Ministry of Education,
Culture, Sports, Science, and Technology, Japan to promote open research for young …

Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations

…, T Odai, M Matsunawa, M Negishi… - Arthritis & …, 2005 - Wiley Online Library
Objective To determine levels of the soluble form of the chemokine fractalkine (sFkn) and its
receptor, CX 3 CR1, in patients with systemic lupus erythematosus (SLE) with …

Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis

M Matsunawa, T Isozaki, T Odai… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To determine levels of soluble fractalkine (sFkn) in rheumatoid arthritis (RA) patients
with and without rheumatoid vasculitis (RV), and to assess the relationship of sFkn levels …

Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia

…, R Hanaoka, H Ide, T Isozaki, M Matsunawa… - Modern …, 2006 - Taylor & Francis
We evaluated the occurrence of cytomegalovirus (CMV) infection and the background
characteristics in twenty-three hospitalized patients with inflammatory connective tissue diseases …

Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia

M Matsunawa, R Yamamoto, M Sanada, A Sato-Otsubo… - Leukemia, 2014 - nature.com
SF3B1 is a core component of the mRNA splicing machinery and frequently mutated in
myeloid neoplasms with myelodysplasia, particularly in those characterized by the presence of …

Vitamin D receptor activation enhances benzo [a] pyrene metabolism via CYP1A1 expression in macrophages

M Matsunawa, D Akagi, S Uno, K Endo-Umeda… - Drug Metabolism and …, 2012 - ASPET
Benzo[a]pyrene (BaP) activates the aryl hydrocarbon (AHR) and induces the expression of
genes involved in xenobiotic metabolism, including CYP1A1. CYP1A1 is involved not only in …

Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis

T Odai, M Matsunawa, R Takahashi… - The Journal of …, 2009 - jrheum.org
Objective. To examine the relation between serum chemokine levels and patient responsiveness
to infliximab, and the influence of infliximab administration on serum chemokine levels. …

Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells

…, M Matsunawa, K Komiyama, M Makishima - The Journal of steroid …, 2009 - Elsevier
The active form of vitamin D 3 , 1α,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], is a potent
ligand for the nuclear receptor vitamin D receptor (VDR) and induces myeloid leukemia cell …

Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia

…, H Kawabata, B Saito, M Matsunawa… - British journal of …, 2004 - Wiley Online Library
Transferrin receptor 1 (TfR1) is a type II membrane protein that mediates cellular iron uptake.
Transferrin receptor 2(TfR2), another receptor for transferrin (Tf), has recently been cloned. …